SLU-PP-332
SLU-PP-332 Product Description — Research Use Only
SLU-PP-332 is a research compound studied as an estrogen-related receptor agonist, commonly referred to as an ERR agonist. It is not a peptide, but it is often grouped within peptide and research-compound catalogs because of its use in metabolic, mitochondrial, endurance-pathway, and exercise-response research.
Research on SLU-PP-332 has most commonly focused on ERRα/β/γ receptor activity, mitochondrial function, exercise-response pathways, endurance research, fatty-acid metabolism, energy balance, and skeletal-muscle adaptation. Published research describes SLU-PP-332 as an ERR pan-agonist that improved aerobic performance in preclinical models, while newer research has focused on optimizing SLU-PP-332-related compounds for stronger drug-like properties and oral bioavailability.
SLU-PP-332 is commonly studied for:
ERR receptor activity — how the compound activates estrogen-related receptor pathways
Mitochondrial function — how cells support energy production and oxidative metabolism
Exercise-response research — pathways that resemble some cellular effects of endurance exercise
Endurance pathways — markers connected to stamina, fatigue resistance, and aerobic output
Fat metabolism — how cells process fatty acids for energy
Skeletal-muscle signaling — how muscle cells adapt to energy demand and stress
Energy balance — how cells regulate fuel use, storage, and metabolic efficiency
SLU-PP-332 is commonly studied because ERR pathways help regulate genes involved in mitochondrial activity, oxidative metabolism, and skeletal-muscle energy use. Research has positioned SLU-PP-332 as an “exercise mimetic” style compound because it activates metabolic signaling pathways associated with endurance adaptation, though current research remains preclinical and investigational.
For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.